Advantages

For the Laboratory:

• Rapid, automated enzyme-linked immunosorbant assay (ELISA) methodology for the VIDAS and miniVIDAS automated immunoassay systems – The Gold Standard
• Easy-to-use, single-dose reagent strips
• Reliable emergency or routine results
• Exceptional analytical performance with validated cutoff
• CV < 4% around the clinical cutoff
• Reportable range up to 10,000 FEU ng/ml with no dilutions

For the Clinician:

• Safe and clinically validated assay for exclusion of DVT and PE as a diagnosis
• > 99% negative predictive value (NPV)
• Excludes 30 – 50% of outpatients suspected of DVT and PE
• Reduced need for invasive and time-consuming examinations
• ELISA results in under 1 hour

For the Administration:

• Reduced costs to exclude venous thromboembolism (VTE)-negative patients
• Reduced length of stay in the Emergency Department
• Better management of limited staff
  and resources